Therapeutic apheresis for autoimmune encephalitis: A nationwide data collection;Therapeutische Apherese bei autoimmuner Enzephalitis: Eine bundesweite Datenerhebung

Nervenarzt

Volumn 84, Issue 4, 2013, Pages 498-507

  Ehrlich, S ^a   Fassbender, C M ^b   Blaes, C ^c   Finke, C ^d   Gunther A ^e   Harms, L ^d   Hoffmann, F ^f   Jahner, K ^f   Klingel, R ^b   Kraft, A ^f   Lempert, T ^g   Tesch, M ^g   Thomsen, J ^h   Topka, H ⁱ   Jochim, J ^j   Veauthier, C ^k   Kohler W ^a  

^a Fachkrankenhaus Hubertusburg   (Germany)

^b Apherese Forschungsinstitut Köln   (Germany)

^c Neurologische Klinik   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e JENA UNIVERSITY HOSPITAL   (Germany)

^f Krankenhaus Martha Maria   (Germany)

^g Medical Park Berlin Humboldtmühle   (Germany)

^h Evangelisches Krankenhaus   (Germany)

ⁱ KLINIKUM BOGENHAUSEN   (Germany)

^j Kinderklinik   (Germany)

^k Hanse Klinikum Stralsund   (Germany)

more..

Author keywords

Apheresis; Autoimmune encephalitis; Immunoadsorption; NMDAR autoantibody; Plasma exchange; Therapeutic

Indexed keywords

4 AMINOBUTYRIC ACID; AUTOANTIBODY; HU ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; VOLTAGE GATED POTASSIUM CHANNEL;

ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; DISEASE SEVERITY; ENCEPHALITIS; HUMAN; IMMUNOADSORPTION; NEUROLOGIC DISEASE; PLASMAPHERESIS; RANKIN SCALE; RELAPSE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AUTOANTIBODIES; BLOOD COMPONENT REMOVAL; BRAIN DISEASES; FEMALE; GERMANY; HASHIMOTO DISEASE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84879879672     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-012-3710-7     Document Type: Article

References (30)

1. Agrawal S, Vincent A, Jacobson L et al (2010) Successfull treatment of anti-N-methyl-d-aspartate receptor limbic encephalitis in a 22-month old child with plasmapheresis and pharmacological immunomodulation. Arch Dis Child 95(4):312
2. Antozzi C, Binelli S (2007) Immunotherapy responsive startle with antibodies to voltage gated potassium channels. J Neurol Psychiatry 78:1281-1282 (Pubitemid 350057301)
3. Bien C (2011) Antikörperassoziierte Erkrankungen der grauen Substanz des ZNS - Diagnostik und Therapie. Nervenarzt 82:986-993
4. Dalmau J, Gleichman A, Huges EG et al (2008) Anti-NMDA-receptor encephalitits: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091-1098
5. Diener H, Putzki N (2008) Leitlinien der Deutschen Gesellschaft für Neurologie Georg Thieme Publishers und http://www.dgn.de
6. Finke C, Kopp U, Prüss H et al (2012) Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry 83(2):195-198
7. Friese M, Magnus T (2011) Autoimmune synaptische Enzephalopathien. Nervenarzt 82(10):1239-1249
8. Galldiks N, Dohmen C, Neveling M et al (2009) Selective immune adsorption treatment of severe Guillain Barré syndrome in the intensive care unit. Neurocrit Care 11:317-321
9. Galldiks N, Burghaus L, Dohmen C et al (2011) Immunoadsorption in patients with chronic inflammatory demyelinating polyradiculoneuropathy with unsatisfactory response to first-line treatment. Eur Neurol 66:183-189
10. Grob D, Simpson D, Mitsumoto H et al (1995) Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology 45:338-344
11. Haberlandt E, Bast T, Holthausen H et al (2011) Limbic encephalitis in children and adolescents. Arch Dis Child 96:186-191
12. Hughes E, Peng X, Gleichmann A et al (2010) Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 30(17):5866-5875
13. Irani S, Vincent A (2011) NMDA receptor antibody encephalitis. Curr Neurol Neurosci Rep 11(3):298-304
14. Klingel R, Heibges A, Fassbender C (2009) Plasma exchange and immunoadsorption for autoimmune neurologic diseases - current guidelines and future perspectives. Atheroscler Suppl 10:129-132
15. Köhler W, Bucka C, Klingel R (2011) A randomised and controlled clinical study comparing immunoadsorption and plasma exchange in myasthenic crisis. J Clin Apher 26:347-355
16. Madrid A, Gil-Peralta A, Gil-Néciga E et al (1996) Morvan's fibrillare corea: remission after plasmapheresis. J Neurol 243(4):350-353 (Pubitemid 26099507)
17. Mauch E, Zwanzger J, Hettich R et al (2011) Immunadsorption bei steroidrefraktärem Schub der Multiplen Sklerose. Nervenarzt 82:1590-1595
18. Merchut M (2010) Management of voltage-gated potassium channel antibody disorders. Neurol Clin 28(4):941-959
19. Mori M, Kuwaba S, Yoshiyama M et al (2002) Successful immune treatment for non-paraneoplastic limbic encephalitis. J Neurol Sci 201(1-2):85-88 (Pubitemid 34876910)
20. Prüss H, Dalmau J, Arolt V et al (2010) Anti-NMDA-Receptor- Enzephalitis. Ein interdisziplinäres Krankheitsbild. Nervenarzt 81(4):396-400
21. Schimmel M, Bien C, Vincent A et al (2009) Successful treatment of anti-N-methyl-D-aspartate receptor encephalitis presenting with catatonia. Arch Dis Child 94(4):314-316
22. Smith J, Dhamija R, Moseley B et al (2011) N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis. Arch Neurol 68(8):1069-1072
23. Suleiman J, Brenner T, Gill D et al (2011) VGKC antibodies in prediatric encephalitis presenting with status epilepticus. Neurology 76(14):1252-1255
24. Sutton DM, Nair RC, Rock G (1989) Complications of plasma exchange. Transfusion 29(2):121-127
25. Trebst C, Bronzlik P, Kielstein J et al (2011) Immunoadsorption therapy for steroid-unresponsive relapses in patients with multiple sclerosis. Blood purification 33:1-6
26. Vincent A, Buckley C, Schott J et al (2004) Potassium channel antibody-associated encephalopahty: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127:701-712 (Pubitemid 38295483)
27. Wandinger K, Saschenberecker S, Stoecker W et al (2011) Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol 231(1-2):86-91
28. Wandingner K, Klingbeil C, Gneiss C et al (2011) Neue serologische Marker zur Differentialdiagnose der Autoimmun-Enzephalitis. J Lab Med 35(6):329-342
29. Weinshenker BG, O'Brien PC, Petterson TM et al (1999) A randomised trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46:878-886
30. Wong S, Saunders M, Larner A et al (2010) An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis. J Neurol Neurosurg Psychiatry 81:1167-1169